• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Avastin: Notice of Opportunity for a Hearing - Instructions for Submissions

Notice of Opportunity for a Hearing 

If you would like to make a statement regarding this topic or provide other comments in a paper submission, it must be filed in four copies. Please send paper comments identified with Docket No. FDA-2010-N-0621 to:

Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852

If you choose to make an electronic submission, please submit comments identified with Docket No. FDA-2010-N-0621 to Regulations.gov.

Except for data and information prohibited from public disclosure under 21 U.S.C. 331(j) or 18 U.S.C. 1905, submissions may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and on the Internet at Regulations.gov.